Université de Montréal has a total of 30 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UNIV MUENCHEN LUDWIG MAXIMILIANS, CENTRE LEON BERARD and ALMAC SCIENCES SCOTLAND LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | United States | 8 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Singapore | 2 | |
#5 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Computer technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Medical preparations | |
#5 | Peptides | |
#6 | Heterocyclic compounds | |
#7 | Microorganisms | |
#8 | Sugars | |
#9 | Combinatorial chemistry | |
#10 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Sauvageau Guy | 14 |
#2 | Gingras Stéphane | 7 |
#3 | Gareau Yves | 6 |
#4 | Hébert Josée | 6 |
#5 | Lemieux Sébastien | 6 |
#6 | Lavallée Vincent-Philippe | 6 |
#7 | Lehnertz Bernhard | 5 |
#8 | Bouvier Michel | 5 |
#9 | Fares Iman | 5 |
#10 | Ruel Réjean | 4 |
Publication | Filing date | Title |
---|---|---|
WO2017096470A1 | Ionic liquids and their use in the extraction of rare earth elements and/or gallium | |
WO2017020128A1 | Markers for acute myeloid leukemias with core binding factor rearrangements and other genetic subtypes and uses thereof | |
WO2016141492A1 | Markers for mll-rearranged acute myeloid leukemias and uses thereof | |
WO2016134450A1 | Imidazopyridazine and imidazothiadiazole compounds | |
WO2016127249A1 | Novel minor histocompatibility antigens and uses thereof | |
EP3201358A1 | Markers of poor prognosis acute myeloid leukemias (amls) and uses thereof | |
WO2014176700A1 | Biosensors for ras-dependent signaling pathways and use thereof | |
WO2014134728A1 | Methods and genes for normalization of gene expression | |
EP2501714A1 | Heteropeptides useful for reducing nonspecific adsorption |